Incidence, severity and impact on functional outcome of persistent hypoperfusion despite large-vessel recanalization, a potential marker of impaired microvascular reperfusion: Systematic review of the clinical literature.


Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
01 2024
Historique:
pmc-release: 23 10 2024
medline: 11 12 2023
pubmed: 24 10 2023
entrez: 23 10 2023
Statut: ppublish

Résumé

The reported incidence of persistent hypoperfusion despite complete recanalization as surrogate for impaired microvascular reperfusion (IMR) has varied widely among clinical studies, possibly due to differences in i) definition of complete recanalization, with only recent Thrombolysis in Cerebral Infarction (TICI) grading schemes allowing distinction between complete (TICI3) and partial recanalization with distal occlusions (TICI2c); ii) operational definition of IMR; and iii) consideration of potential alternative causes for hypoperfusion, notably carotid stenosis, re-occlusion and post-thrombectomy hemorrhage. We performed a systematic review to identify clinical studies that carried out brain perfusion imaging within 72 hrs post-thrombectomy for anterior circulation stroke and reported hypoperfusion rates separately for TICI3 and TICI2c grades. Authors were contacted if this data was missing. We identified eight eligible articles, altogether reporting 636 patients. The incidence of IMR after complete recanalization (i.e., TICI3) tended to decrease with the number of considered alternative causes of hypoperfusion: range 12.5-42.9%, 0-31.6% and 0-9.1% in articles that considered none, two or all three causes, respectively. No study reported the impact of IMR on functional outcome separately for TICI-3 patients. Based on this systematic review, IMR in true complete recanalization appears relatively rare, and reported incidence highly depends on definition used and consideration of confounding factors.

Identifiants

pubmed: 37871624
doi: 10.1177/0271678X231209069
pmc: PMC10905632
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-49

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Stroke. 1991 Oct;22(10):1276-83
pubmed: 1926239
Stroke. 2003 Aug;34(8):e109-37
pubmed: 12869717
J Cereb Blood Flow Metab. 2012 Dec;32(12):2091-9
pubmed: 23047270
Stroke. 2020 Jun;51(6):1736-1742
pubmed: 32404034
J Cereb Blood Flow Metab. 2013 Aug;33(8):1168-72
pubmed: 23652626
CNS Neurosci Ther. 2023 Apr;29(4):1067-1074
pubmed: 36601659
Neuroimage Clin. 2023;37:103340
pubmed: 36739791
Cerebrovasc Dis. 2020;49(1):32-38
pubmed: 32069458
Am J Pathol. 1968 Feb;52(2):437-53
pubmed: 5635861
Neurology. 2022 Feb 22;98(8):e790-e801
pubmed: 34906976
Stroke. 2022 Apr;53(4):1411-1422
pubmed: 35164533
Stroke. 2020 Jul;51(7):2026-2035
pubmed: 32486966
J Cereb Blood Flow Metab. 2023 Jun;43(6):856-868
pubmed: 36748316
Nat Med. 2009 Sep;15(9):1031-7
pubmed: 19718040
J Neurointerv Surg. 2014 Mar;6(2):83-6
pubmed: 23390038
Stroke. 2019 Oct;50(10):2985-2991
pubmed: 31495330
J Neurosurg. 1972 Mar;36(3):303-9
pubmed: 4621825
JAMA. 1995 Oct 4;274(13):1017-25
pubmed: 7563451
Stroke. 1992 May;23(5):712-8
pubmed: 1579969
Stroke. 2019 Mar;50(4):1026–1031
pubmed: 31166683
JAMA. 2022 Mar 1;327(9):826-835
pubmed: 35143603
J Neurointerv Surg. 2019 May;11(5):433-438
pubmed: 30194109
Cerebrovasc Dis. 2022;51(3):394-402
pubmed: 34903681
Stroke. 2021 Apr;52(4):1265-1275
pubmed: 33588589
Stroke. 2022 May;53(5):1597-1605
pubmed: 34937423
Stroke. 1976 Jan 01;7(1):25-30
pubmed: 31815406
Stroke. 2019 Mar;50(3):626-631
pubmed: 30727840
Int J Stroke. 2023 Jul;18(6):712-719
pubmed: 36537618
Stroke. 1982 Jul-Aug;13(4):522-3
pubmed: 7101356
Stroke. 1986 Sep-Oct;17(5):817-30
pubmed: 3532434
Eur Stroke J. 2023 Mar;8(1):259-267
pubmed: 37021148
Brain. 2008 Oct;131(Pt 10):2666-78
pubmed: 18678564
Stroke. 2015 Oct;46(10):2786-94
pubmed: 26316344
Stroke. 2014 Jan;45(1):127-33
pubmed: 24302482
Stroke. 2022 Nov;53(11):3350-3358
pubmed: 36205143
AJNR Am J Neuroradiol. 2016 Feb;37(2):244-51
pubmed: 26450534
J Cereb Blood Flow Metab. 2023 May;43(5):665-679
pubmed: 36524693
J Neurointerv Surg. 2022 Jan;14(1):
pubmed: 33762405
J Am Heart Assoc. 2018 Mar 1;7(5):
pubmed: 29496683
Int J Stroke. 2015 Feb;10(2):143-52
pubmed: 25598025
Neurology. 1972 May;22(5):500-4
pubmed: 4628474
Transl Stroke Res. 2021 Oct;12(5):799-807
pubmed: 33432454
J Cereb Blood Flow Metab. 2011 Sep;31(9):1836-51
pubmed: 21731034
Stroke. 2023 Mar;54(3):873-881
pubmed: 36475464
Interv Neuroradiol. 2014 Jan-Feb;20(1):21-7
pubmed: 24556296
Eur Neurol. 1981;20(3):273-84
pubmed: 6973468
Neurology. 2023 Jan 24;100(4):217-218
pubmed: 36669895
Int J Stroke. 2014 Oct;9(7):860-5
pubmed: 24684804
Transl Stroke Res. 2023 Aug;14(4):446-454
pubmed: 35759064
J Cereb Blood Flow Metab. 2021 Feb;41(2):253-266
pubmed: 32960688
Stroke. 2023 Jun;54(6):1477-1483
pubmed: 37082967
Stroke. 2008 Mar;39(3):870-7
pubmed: 18258831
Stroke. 2021 Dec;52(12):e760-e763
pubmed: 34670411
Neuron. 2015 Jul 1;87(1):95-110
pubmed: 26119027
Stroke. 1997 Oct;28(10):2084-93
pubmed: 9341723
J Neurointerv Surg. 2023 Sep;15(e1):e26-e32
pubmed: 35701108
Ann Neurol. 2022 Nov;92(5):860-870
pubmed: 36054449
J Neurointerv Surg. 2023 Oct;15(10):964-970
pubmed: 36328479
Transl Stroke Res. 2023 Oct;14(5):766-775
pubmed: 36181628
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
J Cereb Blood Flow Metab. 2014 Jan;34(1):2-18
pubmed: 24192635
Stroke. 2013 Sep;44(9):2650-63
pubmed: 23920012
Stroke. 2014 Jun;45(6):1727-32
pubmed: 24876260

Auteurs

Adrien Ter Schiphorst (AT)

Department of Neurology, University Hospital of Montpellier, CHU Gui de Chauliac, Montpellier, France.

Guillaume Turc (G)

Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Université Paris Cité, Inserm U1266, FHU NeuroVasc, Paris, France.

Wagih Ben Hassen (WB)

Department of Neuroradiology, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Université Paris Cité, Inserm U1266, Paris, France.

Catherine Oppenheim (C)

Department of Neuroradiology, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Université Paris Cité, Inserm U1266, Paris, France.

Jean-Claude Baron (JC)

Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Université Paris Cité, Inserm U1266, FHU NeuroVasc, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH